| 1 | [SID131485171] | Active | IC50 | 100 | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) [AID602309, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Active | | IC50 | 100 [uM] | | BioAssay | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) | | AID | 602309 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] | | PubMed | | | Data Table |  |
|
| 2 | [SID131485171] | Active | IC50 | 100 | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) [AID602309, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Active | | IC50 | 100 [uM] | | BioAssay | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) | | AID | 602309 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] | | PubMed | | | Data Table |  |
|
| 3 | [SID131485171] | Active | IC50 | 100 | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) [AID602309, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Active | | IC50 | 100 [uM] | | BioAssay | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) | | AID | 602309 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] | | PubMed | | | Data Table |  |
|
| 4 | [SID131485171] | Active | IC50 | 114.27 | Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] | leucine aminopeptidase [Homo sapiens] [gi:4335941] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Active | | IC50 | 114.27 [uM] | | BioAssay | Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) | | AID | 602407 | | BioAssay type | confirmatory | | Target | leucine aminopeptidase [Homo sapiens] [gi:4335941] | | PubMed | | | Data Table |  |
|
| 5 | [SID131485171] | Active | IC50 | 114.27 | Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] | leucine aminopeptidase [Homo sapiens] [gi:4335941] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Active | | IC50 | 114.27 [uM] | | BioAssay | Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) | | AID | 602407 | | BioAssay type | confirmatory | | Target | leucine aminopeptidase [Homo sapiens] [gi:4335941] | | PubMed | | | Data Table |  |
|
| 6 | [SID131485171] | Inactive | CC50 | | Vero Cytoxicity Assay: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) [AID602317, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Inactive | | CC50 | [uM] | | BioAssay | Vero Cytoxicity Assay: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) | | AID | 602317 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID131485171] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) (3) [AID602316, Type: confirmatory] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) (3) | | AID | 602316 | | BioAssay type | confirmatory | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 8 | [SID131485171] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) (3) [AID602316, Type: confirmatory] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) (3) | | AID | 602316 | | BioAssay type | confirmatory | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 9 | [SID131485171] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) [AID602315, Type: confirmatory] | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) | | AID | 602315 | | BioAssay type | confirmatory | | Target | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] | | PubMed | | | Data Table |  |
|
| 10 | [SID131485171] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) [AID602315, Type: confirmatory] | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 131485171 | | CID | 21494912 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) | | AID | 602315 | | BioAssay type | confirmatory | | Target | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] | | PubMed | | | Data Table |  |
|